Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Akero Therapeutics Inc.
Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
May 10, 2024
From
Akero Therapeutics Inc.
Via
GlobeNewswire
Tickers
AKRO
Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference
May 08, 2024
From
Akero Therapeutics Inc.
Via
GlobeNewswire
Tickers
AKRO
Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer
April 30, 2024
From
Akero Therapeutics Inc.
Via
GlobeNewswire
Tickers
AKRO
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
March 08, 2024
From
Akero Therapeutics Inc.
Via
GlobeNewswire
Tickers
AKRO
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology
March 07, 2024
From
Akero Therapeutics Inc.
Via
GlobeNewswire
Tickers
AKRO
Akero Therapeutics Announces Pricing of Public Offering of Common Stock
March 05, 2024
From
Akero Therapeutics Inc.
Via
GlobeNewswire
Tickers
AKRO
Akero Therapeutics Announces Proposed Public Offering of Common Stock
March 04, 2024
From
Akero Therapeutics Inc.
Via
GlobeNewswire
Tickers
AKRO
Akero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2b HARMONY Study
March 04, 2024
From
Akero Therapeutics Inc.
Via
GlobeNewswire
Tickers
AKRO
Akero Therapeutics to Present Topline Week 96 Results from Phase 2b HARMONY Study Investigating Efruxifermin in Patients with Pre-Cirrhotic MASH
February 29, 2024
From
Akero Therapeutics Inc.
Via
GlobeNewswire
Tickers
AKRO
Akero Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 29, 2024
From
Akero Therapeutics Inc.
Via
GlobeNewswire
Tickers
AKRO
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.